Physician

Basil E Chryssos, M.D.

According to 2025 Medicare claims, Basil Chryssos, M.D. (NPI: 1851383517) practices cardiology in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CARSON TAHOE PHYSICIAN CLINICS (NPI: 1023265717; TIN: 02-0566741) and primary practice location at 89703-4648. Chryssos is affiliated with the Silver State ACO LLC (ACO ID: A2251), participating under the MSSP model.

Chryssos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 735 traditional Medicare patients, billed 2,143 HCPCS/CPT codes, and received $117,103 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,976 prescription claims across 564 beneficiaries totaling $384,248 in drug costs, led by Eliquis (Apixaban). DME data shows 25 claims. Open Payments data shows 13 records totaling $270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $266,294 to $117,103. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $288,484 to $384,248. For DME billing, this smaller-volume category fell sharply in recent years, from $26,556 to $1,943.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,240	5,021	$266,294
2016	2,485	5,977	$317,071
2017	2,198	5,803	$331,236
2018	2,535	6,464	$356,397
2019	2,396	5,077	$277,841
2020	2,101	4,381	$218,333
2021	2,262	4,390	$232,584
2022	2,457	5,153	$257,421
2023	1,274	2,758	$105,083
2024	735	2,143	$117,103

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	532	5,553	$288,484
2016	563	5,953	$341,411
2017	644	5,980	$383,729
2018	712	6,505	$541,233
2019	891	7,019	$783,699
2020	926	8,163	$1,092,301
2021	872	7,054	$1,069,498
2022	886	6,456	$1,065,320
2023	819	4,791	$909,575
2024	564	1,976	$384,248

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	23	181	$23,053
2016	42	295	$19,629
2017	44	312	$14,093
2018	29	282	$15,522
2019	17	172	$12,107
2020	16	154	$11,377
2021	N/R	88	$6,530
2022	N/R	29	$3,147
2023	N/R	24	$2,700
2024	N/R	25	$1,943

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	106	106	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	393	671	$96
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	56	56	$58
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	200	200	$50
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	205	229	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	212	13,343	$254,531
Xarelto	Rivaroxaban	56	3,660	$67,400
Atorvastatin Calcium	Atorvastatin Calcium	161	13,360	$1,918
Metoprolol Succinate	Metoprolol Succinate	127	10,378	$1,712
Metoprolol Tartrate	Metoprolol Tartrate	182	13,976	$1,568

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$1,660
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$284

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$270	Kiniksa Pharmaceuticals International, plc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Basil E. Chryssos, M.D.?

Tedicare shows public-source Medicare data for Basil E. Chryssos, M.D. (NPI 1851383517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Basil E. Chryssos, M.D. have ACO affiliation data?

Basil E. Chryssos, M.D. is shown with ACO affiliation data for Silver State ACO LLC (MSSP, ACO ID A2251).

What billing organization is linked to Basil E. Chryssos, M.D.?

Basil E. Chryssos, M.D. is linked to CARSON TAHOE PHYSICIAN CLINICS (billing NPI 1023265717) in the available physician profile data.

Does Basil E. Chryssos, M.D. have Open Payments data?

Basil E. Chryssos, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.